A Study to Assess the Effects of BPN14770 on Rosuvastatin
Completed · Phase 1
Conditions studied: Healthy Participants
In brief
The primary objective of this study is to investigate the effects of BPN14770 on the pharmacokinetics of the breast cancer resistance protein and organic anion transporting polypeptide 1B1 substrate rosuvastatin in healthy adults.
Key facts
- Study ID
- NCT07011992
- Run by
- Shionogi
- People needed
- 12
- Starts
- 2025-07-18
- Expected to finish
- 2025-08-07
- Last updated by the study team
- 2025-08-14
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- ICON Clinical Research — Lenexa, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.